Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb 6;94(2):223-32.
doi: 10.1016/j.ajhg.2014.01.009.

Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks

Gina M Peloso  1 Paul L Auer  2 Joshua C Bis  3 Arend Voorman  4 Alanna C Morrison  5 Nathan O Stitziel  6 Jennifer A Brody  3 Sumeet A Khetarpal  7 Jacy R Crosby  8 Myriam Fornage  9 Aaron Isaacs  10 Johanna Jakobsdottir  11 Mary F Feitosa  12 Gail Davies  13 Jennifer E Huffman  14 Ani Manichaikul  15 Brian Davis  5 Kurt Lohman  16 Aron Y Joon  17 Albert V Smith  18 Megan L Grove  5 Paolo Zanoni  7 Valeska Redon  7 Serkalem Demissie  19 Kim Lawson  5 Ulrike Peters  20 Christopher Carlson  20 Rebecca D Jackson  21 Kelli K Ryckman  22 Rachel H Mackey  23 Jennifer G Robinson  22 David S Siscovick  24 Pamela J Schreiner  25 Josyf C Mychaleckyj  15 James S Pankow  25 Albert Hofman  26 Andre G Uitterlinden  26 Tamara B Harris  27 Kent D Taylor  28 Jeanette M Stafford  16 Lindsay M Reynolds  16 Riccardo E Marioni  13 Abbas Dehghan  26 Oscar H Franco  26 Aniruddh P Patel  29 Yingchang Lu  30 George Hindy  31 Omri Gottesman  32 Erwin P Bottinger  32 Olle Melander  31 Marju Orho-Melander  33 Ruth J F Loos  34 Stefano Duga  35 Piera Angelica Merlini  36 Martin Farrall  37 Anuj Goel  37 Rosanna Asselta  35 Domenico Girelli  38 Nicola Martinelli  38 Svati H Shah  39 William E Kraus  40 Mingyao Li  41 Daniel J Rader  7 Muredach P Reilly  7 Ruth McPherson  42 Hugh Watkins  43 Diego Ardissino  44 NHLBI GO Exome Sequencing ProjectQunyuan Zhang  12 Judy Wang  12 Michael Y Tsai  45 Herman A Taylor  46 Adolfo Correa  47 Michael E Griswold  47 Leslie A Lange  48 John M Starr  49 Igor Rudan  50 Gudny Eiriksdottir  11 Lenore J Launer  27 Jose M Ordovas  51 Daniel Levy  52 Y-D Ida Chen  28 Alexander P Reiner  53 Caroline Hayward  14 Ozren Polasek  54 Ian J Deary  13 Ingrid B Borecki  12 Yongmei Liu  16 Vilmundur Gudnason  18 James G Wilson  55 Cornelia M van Duijn  10 Charles Kooperberg  20 Stephen S Rich  15 Bruce M Psaty  56 Jerome I Rotter  28 Christopher J O'Donnell  57 Kenneth Rice  4 Eric Boerwinkle  58 Sekar Kathiresan  59 L Adrienne Cupples  60
Affiliations

Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks

Gina M Peloso et al. Am J Hum Genet. .

Abstract

Low-frequency coding DNA sequence variants in the proprotein convertase subtilisin/kexin type 9 gene (PCSK9) lower plasma low-density lipoprotein cholesterol (LDL-C), protect against risk of coronary heart disease (CHD), and have prompted the development of a new class of therapeutics. It is uncertain whether the PCSK9 example represents a paradigm or an isolated exception. We used the "Exome Array" to genotype >200,000 low-frequency and rare coding sequence variants across the genome in 56,538 individuals (42,208 European ancestry [EA] and 14,330 African ancestry [AA]) and tested these variants for association with LDL-C, high-density lipoprotein cholesterol (HDL-C), and triglycerides. Although we did not identify new genes associated with LDL-C, we did identify four low-frequency (frequencies between 0.1% and 2%) variants (ANGPTL8 rs145464906 [c.361C>T; p.Gln121*], PAFAH1B2 rs186808413 [c.482C>T; p.Ser161Leu], COL18A1 rs114139997 [c.331G>A; p.Gly111Arg], and PCSK7 rs142953140 [c.1511G>A; p.Arg504His]) with large effects on HDL-C and/or triglycerides. None of these four variants was associated with risk for CHD, suggesting that examples of low-frequency coding variants with robust effects on both lipids and CHD will be limited.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effects of Human PCSK7 Overexpression in Mouse Liver on Plasma Lipids Plasma TC (A), HDL-C (B), and TG (C) were measured at baseline and at 7 and 14 days after injection of the human PCSK7 or control AAV8 vectors in C57BL/6J male mice. Error bars show standard deviations. p < 0.05 and ∗∗p < 0.01, Student’s unpaired t test.

Similar articles

Cited by

References

    1. Stein E.A., Mellis S., Yancopoulos G.D., Stahl N., Logan D., Smith W.B., Lisbon E., Gutierrez M., Webb C., Wu R. Effect of a monoclonal antibody to PCSK9 on LDL cholesterol. N. Engl. J. Med. 2012;366:1108–1118. - PubMed
    1. Abifadel M., Varret M., Rabès J.P., Allard D., Ouguerram K., Devillers M., Cruaud C., Benjannet S., Wickham L., Erlich D. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat. Genet. 2003;34:154–156. - PubMed
    1. Cohen J., Pertsemlidis A., Kotowski I.K., Graham R., Garcia C.K., Hobbs H.H. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Nat. Genet. 2005;37:161–165. - PubMed
    1. Cohen J.C., Boerwinkle E., Mosley T.H., Jr., Hobbs H.H. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N. Engl. J. Med. 2006;354:1264–1272. - PubMed
    1. Cohen J.C., Hobbs H.H. Genetics. Simple genetics for a complex disease. Science. 2013;340:689–690. - PMC - PubMed

Publication types

MeSH terms